Collectively, the clinical research team at Nexus Oncology has conducted in excess of 250 clinical studies in oncology. Our extensive experience with a range of novel therapeutic approaches includes:
Oral and i.v. cytotoxic agents
Cytostatic agents
Targeted therapies
Hormonal therapies
Gene therapies
Vaccines
Antibodies
Immunomodulators
Supportive care therapies
Phototherapy
Devices
xxHome
xxAbout Nexus Oncology
xxExecutive Management
xxConsultant Medical Advisors
xxBoard of Directors
xxServices
xxWorking with Nexus Oncology
xxUseful Links
xxExperience
> Therapeutic Approaches
xxTumour-type Experience
xxProject Experience
xxCase Studies
xxNewsroom
xxContact Nexus Oncology
xxMeet Nexus Oncology
xxVacancies
